About PD Neurotechnology
PD Neurotechnology is a company based in London (United Kingdom) founded in 2015 by Dimitris Fotiadis, Nikos Moschos, Spyridon Konitsiotis, and Tassos Manos.. PD Neurotechnology has raised $93.34 million across 8 funding rounds from investors including SeedBlink, National Bank of Greece and Onassis Foundation. PD Neurotechnology offers products and services including PDMonitor®. PD Neurotechnology operates in a competitive market with competitors including Empatica, Openwater, iota Biosciences, Magnus Medical and MindAffect, among others.
- Headquarter London, United Kingdom
- Founders Dimitris Fotiadis, Nikos Moschos, Spyridon Konitsiotis, Tassos Manos
- Stage Minicorn
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Pd Neurotechnology Limited
- Date of Incorporation 30 Sep, 2015
- Jurisdiction LONDON
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$93.34 M (USD)
in 8 rounds
-
Latest Funding Round
$2.97 M (USD), Series A
Apr 25, 2023
-
Investors
SeedBlink
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PD Neurotechnology
PD Neurotechnology offers a comprehensive portfolio of products and services, including PDMonitor®. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Wearable system for tracking Parkinson's symptoms and aiding patient care.
Funding Insights of PD Neurotechnology
PD Neurotechnology has successfully raised a total of $93.34M across 8 strategic funding rounds. The most recent funding activity was a Series A round of $2.97 million completed in April 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Series A — $3.0M
-
First Round
First Round
(28 Oct 2016)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2023 | Amount | Series A - PD Neurotechnology | Valuation |
investors |
|
| Aug, 2022 | Amount | Series A - PD Neurotechnology | Valuation | CIC Partners | |
| Jun, 2021 | Amount | Seed - PD Neurotechnology | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in PD Neurotechnology
PD Neurotechnology has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include SeedBlink, National Bank of Greece and Onassis Foundation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A multi-stage technology investment platform is operated globally.
|
Founded Year | Domain | Location | |
|
CIC Partners is engaged in middle-market private equity investments.
|
Founded Year | Domain | Location | |
|
Non-profit organization that fosters art, culture, education, and health initiatives through various programs, residencies, and fellowships, promoting creativity, innovation, and social impact
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by PD Neurotechnology
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - PD Neurotechnology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pd Neurotechnology Comparisons
Competitors of PD Neurotechnology
PD Neurotechnology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Empatica, Openwater, iota Biosciences, Magnus Medical and MindAffect, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of a wrist band to monitor physiological signals
|
|
| domain | founded_year | HQ Location |
Provider of imaging technologies for medical diagnosis and treatments
|
|
| domain | founded_year | HQ Location |
Developer of neurodiagnostic techniques
|
|
| domain | founded_year | HQ Location |
Non-invasive neuromodulation systems for depression treatment are provided.
|
|
| domain | founded_year | HQ Location |
Brain-computer interface headsets are developed for patient communication.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Pd Neurotechnology
Frequently Asked Questions about PD Neurotechnology
When was PD Neurotechnology founded?
PD Neurotechnology was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Where is PD Neurotechnology located?
PD Neurotechnology is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Is PD Neurotechnology a funded company?
PD Neurotechnology is a funded company, having raised a total of $93.34M across 8 funding rounds to date. The company's 1st funding round was a Seed of $100.07K, raised on Oct 28, 2016.
What does PD Neurotechnology do?
PD Neurotechnology was established in 2015 in London, United Kingdom, within the health technology sector. A home-based wearable device is provided for Parkinsons patients to capture kinematic data on motor symptoms and movement disorders. This data is processed via a cloud platform, allowing physicians to review trends, assess disease progression, and recommend tailored treatment plans based on collected metrics.
Who are the top competitors of PD Neurotechnology?
PD Neurotechnology's top competitors include Empatica, Openwater and iota Biosciences.
What products or services does PD Neurotechnology offer?
PD Neurotechnology offers PDMonitor®.
Who are PD Neurotechnology's investors?
PD Neurotechnology has 6 investors. Key investors include SeedBlink, National Bank of Greece, Onassis Foundation, Crimson International Investment, and Big Pi Ventures.
What is PD Neurotechnology's valuation?
The valuation of PD Neurotechnology is $14.71M as of Jun 2021.